214 related articles for article (PubMed ID: 6400007)
21. The effect of hyperbaric oxygen on infarct size in the conscious animal.
Mogelson S; Davidson J; Sobel BE; Roberts R
Eur J Cardiol; 1981; 12(3-4):135-46. PubMed ID: 7286017
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.
Halkin A; Stone GW; Grines CL; Cox DA; Rutherford BD; Esente P; Meils CM; Albertsson P; Farah A; Tcheng JE; Lansky AJ; Mehran R
J Am Coll Cardiol; 2006 Mar; 47(5):951-61. PubMed ID: 16516077
[TBL] [Abstract][Full Text] [Related]
23. [Serum CK/MB-estimated infarct size and other prognostic variables in acute myocardial infarct].
Grande P; Nielsen A; Falch J; Christiansen C
Ugeskr Laeger; 1983 Dec; 145(49):3819-23. PubMed ID: 6665899
[No Abstract] [Full Text] [Related]
24. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
[TBL] [Abstract][Full Text] [Related]
25. The effect of intravenous nitroglycerin therapy on infarct size in patients with acute myocardial infarction.
Raos V; Jeren-Strujić B; Ljutić D; Horvatin-Godler S; Straus B
Acta Med Croatica; 1995; 49(1):5-14. PubMed ID: 7633178
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarction.
Cox DA; Stone PH; Muller JE; Parker C; Hartwell TD; Rutherford JD; Roberts R; Jaffe AS; Hackel DB; Passamani ER
J Am Coll Cardiol; 1987 Nov; 10(5):979-90. PubMed ID: 3312368
[TBL] [Abstract][Full Text] [Related]
27. Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention.
Elsman P; van 't Hof AW; de Boer MJ; Suryapranata H; Borm GF; Hoorntje JC; Ottervanger JP; Gosselink AT; Dambrink JH; Zijlstra F
Am Heart J; 2006 Jun; 151(6):1239.e9-14. PubMed ID: 16781227
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location.
Stone PH; Raabe DS; Jaffe AS; Gustafson N; Muller JE; Turi ZG; Rutherford JD; Poole WK; Passamani E; Willerson JT
J Am Coll Cardiol; 1988 Mar; 11(3):453-63. PubMed ID: 3278032
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiology and prognosis of myocardial infarct and chronic heart failure].
Ertl G; Gaudron P; Eilles C; Kochsiek K
Herz; 1993 Dec; 18 Suppl 1():406-15. PubMed ID: 8125420
[TBL] [Abstract][Full Text] [Related]
31. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
[TBL] [Abstract][Full Text] [Related]
32. Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy.
Chang Sm; Sekandarzad MW; Jiang S; Nagueh S; Spencer W; Lakkis N
Am Heart J; 2003 Dec; 146(6):1112-4. PubMed ID: 14661008
[TBL] [Abstract][Full Text] [Related]
33. The role of infarct size in early and late mortality.
Magnani B; Melandri G
J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S25-8. PubMed ID: 2483228
[TBL] [Abstract][Full Text] [Related]
34. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
[TBL] [Abstract][Full Text] [Related]
35. Troponin T or troponin I or CK-MB (or none?).
Collinson PO
Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
[TBL] [Abstract][Full Text] [Related]
37. Biochemical markers of ischemic injury.
Shell WE; Sobel BE
Circulation; 1976 Mar; 53(3 Suppl):I98-106. PubMed ID: 1253377
[TBL] [Abstract][Full Text] [Related]
38. Considerations in the use of biochemical markers of ischemic injury.
Sobel BE; Roberts R; Larson KB
Circ Res; 1976 May; 38(5 Suppl 1):I99-108. PubMed ID: 1269094
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available.
Smith JL; Ambos HD; Gold HK; Muller JE; Poole WK; Raabe DS; Rude RE; Passamani E; Braunwald E; Sobel BE; Roberts R
Am J Cardiol; 1983 May; 51(8):1294-300. PubMed ID: 6846157
[TBL] [Abstract][Full Text] [Related]
40. Circadian variations of infarct size in acute myocardial infarction.
Suárez-Barrientos A; López-Romero P; Vivas D; Castro-Ferreira F; Núñez-Gil I; Franco E; Ruiz-Mateos B; García-Rubira JC; Fernández-Ortiz A; Macaya C; Ibanez B
Heart; 2011 Jun; 97(12):970-6. PubMed ID: 21525526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]